Infectious complications of solid organ transplantations.

[1]  J. Cohen,et al.  Epstein-Barr virus infection. , 2000, The New England journal of medicine.

[2]  G. Mazariegos,et al.  Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. , 2000, Transplantation.

[3]  Nina Singh,et al.  Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. , 2000, Transplantation.

[4]  B. Alexander,et al.  Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. , 2000, Transplantation.

[5]  V. Calvez,et al.  Outcome of kidney transplant recipients with previous human herpesvirus-8 infection. , 2000, Transplantation.

[6]  H. Einsele,et al.  Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. , 2000, The Journal of infectious diseases.

[7]  Y. Chang,et al.  Kaposi's sarcoma. , 2000, The New England journal of medicine.

[8]  A. Humar,et al.  Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. , 2000, The Journal of infectious diseases.

[9]  P. Griffiths,et al.  Betaherpesviruses in transplant recipients. , 2000, The Journal of antimicrobial chemotherapy.

[10]  F. Baldanti,et al.  High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders , 2000, Journal of Clinical Microbiology.

[11]  I. Sia,et al.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. , 2000, Clinical microbiology reviews.

[12]  E. Kieff,et al.  Epstein-barr virus-induced posttransplant lymphoproliferative disorders , 1999 .

[13]  R. Busuttil,et al.  Prophylactic Fluconazole in Liver Transplant Recipients , 1999, Annals of Internal Medicine.

[14]  E. Trulock,et al.  The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation. , 1999, Transplantation.

[15]  G. Verhoef,et al.  Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis , 1999, Journal of Clinical Microbiology.

[16]  Nina Singh,et al.  Invasive aspergillosis in transplant recipients. , 1999, Medicine.

[17]  A. Arroliga,et al.  Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Knechtle,et al.  Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. , 1998, Transplantation.

[19]  W. Irish,et al.  Epidemiology of legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  S. Zielen,et al.  Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. , 1998, Transplantation.

[21]  M. Wernli,et al.  Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. , 1998, The New England journal of medicine.

[22]  Nina Singh,et al.  Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  K. Byth,et al.  Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation. , 1998, Transplantation.

[24]  F. Baldanti,et al.  Ganciclovir resistance as a result of oral ganciclovir in a heart transplant recipient with multiple human cytomegalovirus strains in blood. , 1998, Transplantation.

[25]  J. Aster,et al.  Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. , 1998, The New England journal of medicine.

[26]  P. Muñoz,et al.  Pneumonia After Heart Transplantation: A Multiinstitutional Study , 1998 .

[27]  R. Rubin,et al.  Infection in organ-transplant recipients. , 1998, The New England journal of medicine.

[28]  D. Snydman,et al.  Infective Endocarditis in Solid Organ Transplant Recipients , 1998 .

[29]  R. Avery.  Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients. , 1998, Current opinion in cardiology.

[30]  E. Bouza,et al.  Rhodococcus equi infection in transplant recipients: case report and review of the literature. , 1998, Transplantation.

[31]  S. Strom,et al.  Current status of intestinal transplantation in children. , 1998, Journal of pediatric surgery.

[32]  M. Gettman,et al.  Urological complications after kidney-pancreas transplantation. , 1998, The Journal of urology.

[33]  Nina Singh,et al.  Invasive aspergillosis in liver transplant recipients in the 1990s. , 1997, Transplantation.

[34]  Nina Singh,et al.  Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. , 1997, Transplantation.

[35]  C. Chaparro,et al.  Infections in lung transplant recipients. , 1997, Clinics in chest medicine.

[36]  C. Cantarell,et al.  Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA. , 1997, Transplantation.

[37]  T. Starzl,et al.  Brain abscess in solid organ transplant recipients receiving cyclosporine-based immunosuppression. , 1997, Archives of surgery.

[38]  D. Snydman,et al.  Effect of Cytomegalovirus Infection Status on First-Year Mortality Rates among Orthotopic Liver Transplant Recipients , 1997, Annals of Internal Medicine.

[39]  I. Marino,et al.  Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  C. Payá,et al.  Infections in solid-organ transplant recipients , 1997, Clinical microbiology reviews.

[41]  R. Wiesner,et al.  Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. , 1996, Transplantation.

[42]  S. Todo,et al.  Infectious complications after small bowel transplantation in adults: an update. , 1996, Transplantation proceedings.

[43]  J. Perfect,et al.  Fungal Infections in Lung and Heart‐Lung Transplant Recipients: Report of 9 Cases and Review of the Literature , 1996, Medicine.

[44]  J. Fung,et al.  Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  C. Yancy,et al.  Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  J. Maurer,et al.  Aspergillus infection in single and double lung transplant recipients. , 1996, Transplantation.

[47]  N. Warren,et al.  Actinomycosis, nocardiosis, and actinomycetoma. , 1996, Dermatologic clinics.

[48]  R. Busuttil,et al.  Infections in liver transplant recipients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  N. Cary,et al.  Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  N. Rolando,et al.  Bacterial and fungal infections after liver transplantation: An analysis of 284 patients , 1995, Hepatology.

[51]  J. Velosa,et al.  Infectious complications following pancreatic transplantation: incidence, microbiological and clinical characteristics, and outcome. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  V. Yu,et al.  Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  E. Lennette,et al.  An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. , 1995, Transplantation.

[54]  D. Glotz,et al.  Invasive aspergillosis after transplantation. , 1995, Transplantation proceedings.

[55]  O. Ringdén,et al.  Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. , 1995, Transplantation.

[56]  T. Habermann,et al.  Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[57]  M. Samore,et al.  Risk factors for invasive fungal infections complicating orthotopic liver transplantation. , 1994, The Journal of infectious diseases.

[58]  N. Kneteman,et al.  Comparative Risk of Bloodstream Infection in Organ Transplant Recipients , 1994, Infection Control & Hospital Epidemiology.

[59]  C. Payá,et al.  Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  R. Rubin,et al.  Clinical aspects of fungal infection in organ transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  F. Detterbeck,et al.  Infectious complications of lung transplantation. Impact of cystic fibrosis. , 1994, American journal of respiratory and critical care medicine.

[62]  L. Miller,et al.  Infection after heart transplantation: a multiinstitutional study , 1994 .

[63]  W. Petri,et al.  Infections in heart transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  V. Yu,et al.  Invasive aspergillosis in liver transplant recipients: association with candidemia and consumption coagulopathy and failure of prophylaxis with low-dose amphotericin B. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  J. Cooper,et al.  The donor lung: infectious and pathologic factors affecting outcome in lung transplantation. , 1993, The Journal of thoracic and cardiovascular surgery.

[66]  M. Kramer,et al.  Infectious complications in heart-lung transplantation. Analysis of 200 episodes. , 1993, Archives of internal medicine.

[67]  J. Loyd,et al.  Infection in the transplanted and native lung after single lung transplantation. , 1993, Chest.

[68]  A. Mehta,et al.  Lung transplantation: the Cleveland Clinic experience. , 1993, Cleveland Clinic journal of medicine.

[69]  R. Rubin.  Infectious disease complications of renal transplantation. , 1993, Kidney international.

[70]  J. Thompson,et al.  Disseminated Strongyloides stercoralis infection. , 1993, Southern medical journal (Birmingham, Ala. Print).

[71]  A. Tzakis,et al.  Selective decontamination in pediatric liver transplants. A randomized prospective study. , 1993, Transplantation.

[72]  C. Payá,et al.  Fungal infections in solid-organ transplantation. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  J. Copeland,et al.  Coccidioidomycosis and heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[74]  T. F. Smith,et al.  Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. , 1993, Journal of hepatology.

[75]  J. Serody,et al.  Blastomycosis in transplant recipients: report of a case and review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  T. Starzl,et al.  Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. , 1992, The Journal of infectious diseases.

[77]  V. Yu,et al.  Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. , 1992, American journal of infection control.

[78]  R. De Maria,et al.  Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[79]  J. Emond,et al.  Patterns of infection after pediatric liver transplantation. , 1992, American journal of diseases of children.

[80]  B. Radovancević,et al.  Bacterial mediastinitis after heart transplantation. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[81]  P. D. del Nido,et al.  Toxoplasmosis in pediatric recipients of heart transplants. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[82]  G. Patterson,et al.  Infectious complications following isolated lung transplantation. , 1992, Chest.

[83]  G. Klintmalm,et al.  Selective amphotericin B prophylaxis in the reduction of fungal infections after liver transplant. , 1992, Transplantation proceedings.

[84]  J. Emond,et al.  Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. , 1991, Reviews of infectious diseases.

[85]  J. Cofer,et al.  Analysis of severe infections (INF) after 180 consecutive liver transplants: the impact of amphotericin B prophylaxis for reducing the incidence and severity of fungal infections. , 1991, Transplantation proceedings.

[86]  R. Fisher,et al.  Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. , 1990, The New England journal of medicine.

[87]  J. Dummer,et al.  Infectious complications in pulmonary allograft recipients. , 1990, Clinics in chest medicine.

[88]  E. Gilbert,et al.  Increased risk of pneumococcal infections in cardiac transplant recipients. , 1990, Transplantation.

[89]  K. Gottesdiener.  Transplanted infections: donor-to-host transmission with the allograft. , 1989, Annals of internal medicine.

[90]  T. F. Smith,et al.  Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. , 1989, Mayo Clinic proceedings.

[91]  S. Chapman,et al.  Nocardial Infections in Renal Transplant Recipients , 1989, Medicine.

[92]  T. Starzl,et al.  Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. , 1988, The Journal of infectious diseases.

[93]  P E Oyer,et al.  Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. , 1987, Annals of internal medicine.

[94]  W. Schaffner,et al.  Opportunistic strongyloidiasis in renal transplant recipients. , 1986, Transplantation.

[95]  T. Peters,et al.  TRANSMISSION OF TUBERCULOSIS BY KIDNEY TRANSPLANTATION , 1984, Transplantation.

[96]  Y. Naot,et al.  Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. , 1983, Annals of internal medicine.

[97]  J. Galgiani,et al.  Coccidioidomycosis in renal replacement therapy. , 1982, Archives of internal medicine.

[98]  R. Rubin,et al.  A controlled study of trimethoprim-sulfamethoxazole prophylaxis of urinary tract infection in renal transplant recipients. , 1982, Reviews of infectious diseases.

[99]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .